Exact Mass: 283.2333578

Exact Mass Matches: 283.2333578

Found 99 metabolites which its exact mass value is equals to given mass value 283.2333578, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Levallorphan

(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-4-ol

C19H25NO (283.193604)


An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Histrionicotoxin

(2S,6R,10S,11S)-11-[(E)-but-1-en-3-ynyl]-2-[(E)-pent-2-en-4-ynyl]-1-azaspiro[5.5]undecan-10-ol

C19H25NO (283.193604)


An azaspiro compound that is 1-azaspiro[5.5]undecane substituted by a hydroxy group at position 8, a but-1-en-3-yn-1-yl group at position 7 and a pent-3-en-1-yn-5-yl group at position 2 (the 2S,6R,7S,8S stereoisomer).

   

N-Dealkylated tolterodine

4-methyl-2-[(1R)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.193604)


N-Dealkylated tolterodine is only found in individuals that have used or taken tolterodine. N-Dealkylated tolterodine is a metabolite of tolterodine. N-Dealkylated tolterodine belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.

   

(2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralin

N,N-dimethyl-5-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine

C18H25N3 (283.204837)


   

Tesmilifene

N,N-Diethyl-2-((4-phenylmethyl)phenoxy)-ethanamine hydrochloride

C19H25NO (283.193604)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   
   

N-(ortho-methoxybenzyl)-4-ethylamphetamine

N-(ortho-methoxybenzyl)-4-ethylamphetamine

C19H25NO (283.193604)


   

N-Dodecanoyl-DL-homoserine lactone

N-Dodecanoyl-DL-homoserine lactone

C16H29NO3 (283.2147324)


   

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

C19H25NO (283.193604)


   

N-methyl-16-hydroxyhexadec-4-enamide

N-methyl-16-hydroxyhexadec-4-enamide

C17H33NO2 (283.2511158)


   

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

C19H25NO (283.193604)


   

2,4-Tetradecadien-8,10-diynoic acid piperidide

2,4-Tetradecadien-8,10-diynoic acid piperidide

C19H25NO (283.193604)


   

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

C19H25NO (283.193604)


   
   
   

C12-homoserine lactone

N-Dodecanoyl-DL-homoserine lactone

C16H29NO3 (283.2147324)


CONFIDENCE standard compound; INTERNAL_ID 205

   

N-dodecanoyl-S-homoserine lactone

N-dodecanoyl-S-homoserine lactone

C16H29NO3 (283.2147324)


   

Propoxyphene carbinol

[S-(R*,S*)]-alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenylphenethyl alcohol

C19H25NO (283.193604)


   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

Prosafrinine

11-(5S-hydroxy-6S-methylpiperidin-2R-yl)undecan-3-one

C17H33NO2 (283.2511158)


   

C12-HSL

N-[(3S)-tetrahydro-2-oxo-3-furanyl]-dodecanamide

C16H29NO3 (283.2147324)


   

epi-Tumonoic Acid D

epi-Tumonoic Acid D

C16H29NO3 (283.2147324)


   

N-Dealkylatedtolterodine

4-methyl-2-[(1S)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.193604)


   

SPH id17:2

iso (4E,13Z,15-methyl-d16:2) sphingosine

C17H33NO2 (283.2511158)


   

Drobuline

Drobuline

C19H25NO (283.193604)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

   

1,2-Ethanediamine,N1-(phenylmethyl)-N2-[2-[(phenylmethyl)amino]ethyl]-

1,2-Ethanediamine,N1-(phenylmethyl)-N2-[2-[(phenylmethyl)amino]ethyl]-

C18H25N3 (283.204837)


   

tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate

tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate

C15H29N3O2 (283.2259654)


   

1-[2-{Bis[(2H3)methyl]amino}-1-(4-methoxyphenyl)ethyl]cyclohexanol

1-[2-{Bis[(2H3)methyl]amino}-1-(4-methoxyphenyl)ethyl]cyclohexanol

C17H21D6NO2 (283.241831268)


   

2-amino-1,1-diphenylheptan-1-ol

2-amino-1,1-diphenylheptan-1-ol

C19H25NO (283.193604)


   

tert-butyl 1-(piperidin-4-yl)

tert-butyl 1-(piperidin-4-yl)

C15H29N3O2 (283.2259654)


   

1-Benzyl-[1,4-bipiperidine]-4-carbonitrile

1-Benzyl-[1,4-bipiperidine]-4-carbonitrile

C18H25N3 (283.204837)


   

Alentemol

Alentemol

C19H25NO (283.193604)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

(3S,5S)-5-((1S,3S)-1-AZIDO-4-HYDROXY-3-ISOPROPYLBUTYL)-DIHYDRO-3-ISOPROPYLFURAN-2(3H)-ONE

(3S,5S)-5-((1S,3S)-1-AZIDO-4-HYDROXY-3-ISOPROPYLBUTYL)-DIHYDRO-3-ISOPROPYLFURAN-2(3H)-ONE

C14H25N3O3 (283.189582)


   

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

C17H30ClN (283.20666500000004)


   
   
   

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

C19H25NO (283.193604)


   

trans-4-(4-Heptylcyclohexyl)benzonitrile

trans-4-(4-Heptylcyclohexyl)benzonitrile

C20H29N (283.2299874)


   

tert-butyl 4-(4-aminopiperidin-1-yl)piperidine-1-carboxylate

tert-butyl 4-(4-aminopiperidin-1-yl)piperidine-1-carboxylate

C15H29N3O2 (283.2259654)


   

Ethyl (8-ethyl-8-methyl-9-oxa-2-azaspiro[5.5]undec-2-yl)acetate

Ethyl (8-ethyl-8-methyl-9-oxa-2-azaspiro[5.5]undec-2-yl)acetate

C16H29NO3 (283.2147324)


   

HEXADECYL ISOTHIOCYANATE

HEXADECYL ISOTHIOCYANATE

C17H33NS (283.2333578)


   

(E)-tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate

(E)-tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate

C14H26BNO4 (283.1954786)


   

2-DIISOBUTYLCARBAMOYL-CYCLOHEXANECARBOXYLIC ACID

2-DIISOBUTYLCARBAMOYL-CYCLOHEXANECARBOXYLIC ACID

C16H29NO3 (283.2147324)


   

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

C19H25NO (283.193604)


   

benzyldimethyloctylammonium chloride

benzyldimethyloctylammonium chloride

C17H30ClN (283.20666500000004)


   

tert-Butyl 4-methyl-4-(piperazin-1-yl)piperidine-1-carboxylate

tert-Butyl 4-methyl-4-(piperazin-1-yl)piperidine-1-carboxylate

C15H29N3O2 (283.2259654)


   

levallorphan hydrogen tartrate

levallorphan hydrogen tartrate

C19H25NO (283.193604)


   

Tripiperidinophosphine

Tripiperidinophosphine

C15H30N3P (283.217723)


   

3-trimethylsilylmethyl-4-trimethylsilyl-n-tert-butylcrotonaldimine

3-trimethylsilylmethyl-4-trimethylsilyl-n-tert-butylcrotonaldimine

C15H33NSi2 (283.21514179999997)


   
   

Sdccgsbi-0050749.P002

Sdccgsbi-0050749.P002

C19H25NO (283.193604)


   

3,4-Dihydroxybenzoate-spermidine

3,4-Dihydroxybenzoate-spermidine

C14H25N3O3+2 (283.189582)


   

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

C19H25NO (283.193604)


   
   

[(2R,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2S,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2R,3R,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2S,3S,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2R,3R,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

(2S)-2-methylheptadecanoate

(2S)-2-methylheptadecanoate

C18H35O2- (283.263691)


A 2-methyl fatty acid anion that is the conjugate base of (2S)-2-methyl-heptadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(E)-Delta-oxomycolate

(E)-Delta-oxomycolate

C16H27O4- (283.1909242)


   

4-Spiro-(N-methylpiperidyl)-2,2-dimethyl-1,2,3,4-tetrahydro-gamma-carboline

4-Spiro-(N-methylpiperidyl)-2,2-dimethyl-1,2,3,4-tetrahydro-gamma-carboline

C18H25N3 (283.204837)


   

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]acetamide

C16H29NO3 (283.2147324)


   

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]propanamide

C16H29NO3 (283.2147324)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]butanamide

C16H29NO3 (283.2147324)


   

3-(1-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(1-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C18H25N3 (283.204837)


   

3-(3-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(3-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C18H25N3 (283.204837)


   

(Z)-N-(2-hydroxyethyl)pentadec-9-enamide

(Z)-N-(2-hydroxyethyl)pentadec-9-enamide

C17H33NO2 (283.2511158)


   

levallorphan

levallorphan

C19H25NO (283.193604)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Tesmilifene

Tesmilifene

C19H25NO (283.193604)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

Octadecanoate

Octadecanoate

C18H35O2 (283.263691)


A fatty acid anion 18:0 that is the conjugate base of octadecanoic acid (stearic acid). Stearates have a variety of uses in the pharmaceutical industry.

   

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

C19H25NO (283.193604)


   

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

C19H25NO (283.193604)


   

fatty acid anion 18:0

fatty acid anion 18:0

C18H35O2 (283.263691)


Any saturated fatty acid anion containing 18 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.

   

AEA(15:1)

AEA(15:1)

C17H33NO2 (283.2511158)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

N-Dodecanoyl-homoserine lactone

N-Dodecanoyl-homoserine lactone

C16H29NO3 (283.2147324)


   
   

AS19

AS19

C18H25N3 (283.204837)


AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM. AS19 is selective for 5-HT7 over 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT5A receptors (Kis = 89.7 nM, 490 nM, 6.6 nM and 98.5 nM, respectively). AS19 enhances memory consolidation and reverses Scopolamine- or Dizocilpine-induced amnesia[1][2][3].

   

(2s)-1-[(2r)-2-methyldecanoyl]pyrrolidine-2-carboxylic acid

(2s)-1-[(2r)-2-methyldecanoyl]pyrrolidine-2-carboxylic acid

C16H29NO3 (283.2147324)


   

1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

C16H29NO3 (283.2147324)


   

1-(2-methyldecanoyl)pyrrolidine-2-carboxylic acid

1-(2-methyldecanoyl)pyrrolidine-2-carboxylic acid

C16H29NO3 (283.2147324)


   

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

C16H29NO3 (283.2147324)


   

(2r,6s,7s,8r)-7-[(1e)-but-1-en-3-yn-1-yl]-2-[(2e)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2r,6s,7s,8r)-7-[(1e)-but-1-en-3-yn-1-yl]-2-[(2e)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

(2e,4e,6e,10e)-1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

(2e,4e,6e,10e)-1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

C19H25NO (283.193604)


   

(2s,6r,7s,8r)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8r)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

3-methyl-2-(non-2-en-1-yl)-1h-quinolin-4-one

3-methyl-2-(non-2-en-1-yl)-1h-quinolin-4-one

C19H25NO (283.193604)


   

(2e,4e,12z)-n-(3-methylbutyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

(2e,4e,12z)-n-(3-methylbutyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

C19H25NO (283.193604)


   

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

n-[(3s)-2-oxooxolan-3-yl]dodecanimidic acid

n-[(3s)-2-oxooxolan-3-yl]dodecanimidic acid

C16H29NO3 (283.2147324)


   

1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

C19H25NO (283.193604)


   

n-(2-oxooxolan-3-yl)dodecanimidic acid

n-(2-oxooxolan-3-yl)dodecanimidic acid

C16H29NO3 (283.2147324)


   

3-methyl-2-[(2e)-non-2-en-1-yl]-1h-quinolin-4-one

3-methyl-2-[(2e)-non-2-en-1-yl]-1h-quinolin-4-one

C19H25NO (283.193604)


   

(2r)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

(2r)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldecane-1,3-dione

C16H29NO3 (283.2147324)


   

7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-indeno[2,1-b]pyridin-7-one

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-indeno[2,1-b]pyridin-7-one

C19H25NO (283.193604)


   

(2r,6s,7s,8r)-7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2r,6s,7s,8r)-7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-cyclopenta[g]quinolin-7-one

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-cyclopenta[g]quinolin-7-one

C19H25NO (283.193604)


   

n-[(3e,5e)-6,8-dimethyldeca-3,5,9-trien-2-yl]benzenecarboximidic acid

n-[(3e,5e)-6,8-dimethyldeca-3,5,9-trien-2-yl]benzenecarboximidic acid

C19H25NO (283.193604)